179 related articles for article (PubMed ID: 23236061)
1. Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity.
Yagita Y; Kuse N; Kuroki K; Gatanaga H; Carlson JM; Chikata T; Brumme ZL; Murakoshi H; Akahoshi T; Pfeifer N; Mallal S; John M; Ose T; Matsubara H; Kanda R; Fukunaga Y; Honda K; Kawashima Y; Ariumi Y; Oka S; Maenaka K; Takiguchi M
J Virol; 2013 Feb; 87(4):2253-63. PubMed ID: 23236061
[TBL] [Abstract][Full Text] [Related]
2. Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.
Akahoshi T; Chikata T; Tamura Y; Gatanaga H; Oka S; Takiguchi M
J Virol; 2012 Feb; 86(4):1971-81. PubMed ID: 22156528
[TBL] [Abstract][Full Text] [Related]
3. Selection of TI8-8V mutant associated with long-term control of HIV-1 by cross-reactive HLA-B*51:01-restricted cytotoxic T cells.
Kuse N; Akahoshi T; Gatanaga H; Ueno T; Oka S; Takiguchi M
J Immunol; 2014 Nov; 193(10):4814-22. PubMed ID: 25305317
[TBL] [Abstract][Full Text] [Related]
4. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
[TBL] [Abstract][Full Text] [Related]
5. Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8
Zhang Y; Murakoshi H; Chikata T; Akahoshi T; Tran GV; Nguyen TV; Gatanaga H; Nguyen KV; Oka S; Kuse N; Takiguchi M
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361435
[TBL] [Abstract][Full Text] [Related]
6. Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.
Koizumi H; Hashimoto M; Fujiwara M; Murakoshi H; Chikata T; Borghan MA; Hachiya A; Kawashima Y; Takata H; Ueno T; Oka S; Takiguchi M
J Virol; 2010 Jun; 84(11):5508-19. PubMed ID: 20335254
[TBL] [Abstract][Full Text] [Related]
7. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
[TBL] [Abstract][Full Text] [Related]
8. Escape mutation selected by Gag28-36-specific cytotoxic T cells in HLA-A*2402-positive HIV-1-infected donors.
Koizumi H; Iwatani T; Tanuma J; Fujiwara M; Izumi T; Oka S; Takiguchi M
Microbes Infect; 2009 Feb; 11(2):198-204. PubMed ID: 19063987
[TBL] [Abstract][Full Text] [Related]
9. Different Effects of Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Cytotoxic T Lymphocyte Recognition between HIV-1 Subtype B and Subtype A/E Infections.
Kuse N; Rahman MA; Murakoshi H; Tran GV; Chikata T; Koyanagi M; Nguyen KV; Gatanaga H; Oka S; Takiguchi M
J Virol; 2015 Jul; 89(14):7363-72. PubMed ID: 25972553
[TBL] [Abstract][Full Text] [Related]
10. Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts.
Fujiwara M; Tanuma J; Koizumi H; Kawashima Y; Honda K; Mastuoka-Aizawa S; Dohki S; Oka S; Takiguchi M
J Virol; 2008 Jan; 82(1):138-47. PubMed ID: 17959671
[TBL] [Abstract][Full Text] [Related]
11. Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication.
Honda K; Zheng N; Murakoshi H; Hashimoto M; Sakai K; Borghan MA; Chikata T; Koyanagi M; Tamura Y; Gatanaga H; Oka S; Takiguchi M
Eur J Immunol; 2011 Jan; 41(1):97-106. PubMed ID: 21182081
[TBL] [Abstract][Full Text] [Related]
12. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.
Yager N; Robinson N; Brown H; Flanagan P; Frater J; Fidler S; Weber J; Phillips R;
AIDS; 2013 Jan; 27(3):313-23. PubMed ID: 23095315
[TBL] [Abstract][Full Text] [Related]
15. Broad Recognition of Circulating HIV-1 by HIV-1-Specific Cytotoxic T-Lymphocytes with Strong Ability to Suppress HIV-1 Replication.
Murakoshi H; Kuse N; Akahoshi T; Zhang Y; Chikata T; Borghan MA; Gatanaga H; Oka S; Sakai K; Takiguchi M
J Virol; 2019 Jan; 93(1):. PubMed ID: 30333175
[TBL] [Abstract][Full Text] [Related]
16. T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics.
Akahoshi T; Gatanaga H; Kuse N; Chikata T; Koyanagi M; Ishizuka N; Brumme CJ; Murakoshi H; Brumme ZL; Oka S; Takiguchi M
PLoS Pathog; 2020 Dec; 16(12):e1009177. PubMed ID: 33370400
[TBL] [Abstract][Full Text] [Related]
17. Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1.
Zhang Y; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Murakoshi H; Takiguchi M
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699092
[TBL] [Abstract][Full Text] [Related]
18. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
Tsai MC; Singh S; Adland E; Goulder P
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
[TBL] [Abstract][Full Text] [Related]
19. Multilayered defense in HLA-B51-associated HIV viral control.
Zhang Y; Peng Y; Yan H; Xu K; Saito M; Wu H; Chen X; Ranasinghe S; Kuse N; Powell T; Zhao Y; Li W; Zhang X; Feng X; Li N; Leligdowicz A; Xu X; John M; Takiguchi M; McMichael A; Rowland-Jones S; Dong T
J Immunol; 2011 Jul; 187(2):684-91. PubMed ID: 21670313
[TBL] [Abstract][Full Text] [Related]
20. Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunity.
Gatanaga H; Murakoshi H; Hachiya A; Hayashida T; Chikata T; Ode H; Tsuchiya K; Sugiura W; Takiguchi M; Oka S
Clin Infect Dis; 2013 Oct; 57(7):1051-5. PubMed ID: 23797286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
